<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>同写意 | wechat-feeds</title><link>http://MzA4MzgzMDM5Mg.favicon.privacyhide.com/favicon.ico</link><description>一个以新药创制为核心，汇集国内一流研发精英的大型交流与价值分享平台。“同筑技术人生路，写意中国新药魂”是同写意的初衷与愿景。秉承汇集“一线、一流”，讲求“实用、实在、时效”的原则。</description><managingEditor> (hellodword)</managingEditor><pubDate>Mon, 29 Mar 2021 07:21:31 +0800</pubDate><image><url>http://MzA4MzgzMDM5Mg.favicon.privacyhide.com/favicon.ico</url><title>同写意 | wechat-feeds</title><link>http://MzA4MzgzMDM5Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>现场丨从金鸡湖导航卓越医药BD专家之路</title><link>https://mp.weixin.qq.com/s/ijcw9pi4pVSnRonA4TujDQ</link><description></description><content:encoded><![CDATA[现场丨从金鸡湖导航卓越医药BD专家之路]]></content:encoded><pubDate>Sun, 28 Mar 2021 23:44:52 +0800</pubDate></item><item><title>小分子药物的困境与出路</title><link>https://mp.weixin.qq.com/s/9WZnxp5wWDMmKbVZCTWNeg</link><description></description><content:encoded><![CDATA[小分子药物的困境与出路]]></content:encoded><pubDate>Sun, 28 Mar 2021 23:44:52 +0800</pubDate></item><item><title>我国获“突破性治疗药物”企业在地域分布上有哪些特点？</title><link>https://mp.weixin.qq.com/s/xcUyj0714ucXAODGu-31yw</link><description></description><content:encoded><![CDATA[我国获“突破性治疗药物”企业在地域分布上有哪些特点？]]></content:encoded><pubDate>Sun, 28 Mar 2021 23:44:52 +0800</pubDate></item><item><title>因美纳李庆：不断拓宽产业“朋友圈”，解码基因组学助力人类健康事业</title><link>https://mp.weixin.qq.com/s/SNXoClJRw-40k_MRe58Prg</link><description></description><content:encoded><![CDATA[因美纳李庆：不断拓宽产业“朋友圈”，解码基因组学助力人类健康事业]]></content:encoded><pubDate>Sun, 28 Mar 2021 23:44:52 +0800</pubDate></item><item><title>2020年营收增长超40%，药明生物CDMO巨头之路走到哪一步？</title><link>https://mp.weixin.qq.com/s/wKxIyZTuFu_h-IGIDvrPeQ</link><description></description><content:encoded><![CDATA[2020年营收增长超40%，药明生物CDMO巨头之路走到哪一步？]]></content:encoded><pubDate>Sat, 27 Mar 2021 19:55:47 +0800</pubDate></item><item><title>人间最美四月天，医药邂逅太湖湾</title><link>https://mp.weixin.qq.com/s/EDvrrL8fsimE8zqXr8G0kg</link><description></description><content:encoded><![CDATA[人间最美四月天，医药邂逅太湖湾]]></content:encoded><pubDate>Sat, 27 Mar 2021 19:55:47 +0800</pubDate></item><item><title>505(b)(2)申请的审评时间分析</title><link>https://mp.weixin.qq.com/s/LVsldwTZzVH64VQ3hc8VpQ</link><description></description><content:encoded><![CDATA[505(b)(2)申请的审评时间分析]]></content:encoded><pubDate>Sat, 27 Mar 2021 19:55:47 +0800</pubDate></item><item><title>获批及在研ADC药物和靶点一览，预测肿瘤市场规模超160亿美元</title><link>https://mp.weixin.qq.com/s/B7lPctRSTsUDZh6k-Z-WEg</link><description></description><content:encoded><![CDATA[获批及在研ADC药物和靶点一览，预测肿瘤市场规模超160亿美元]]></content:encoded><pubDate>Sat, 27 Mar 2021 19:55:47 +0800</pubDate></item><item><title>杰克说药丨口服长效紫杉醇的失败​——Odonate Therapeutics破产</title><link>https://mp.weixin.qq.com/s/XQvx_S5ky4xb1JKz_NNXEg</link><description></description><content:encoded><![CDATA[杰克说药丨口服长效紫杉醇的失败​——Odonate Therapeutics破产]]></content:encoded><pubDate>Fri, 26 Mar 2021 23:39:31 +0800</pubDate></item><item><title>基石药业公布2020年全年业绩及公司进展</title><link>https://mp.weixin.qq.com/s/GShNljQpo7FEZemfy4uLaw</link><description></description><content:encoded><![CDATA[基石药业公布2020年全年业绩及公司进展]]></content:encoded><pubDate>Fri, 26 Mar 2021 23:39:31 +0800</pubDate></item><item><title>关注杜丨又一膀胱功能障碍药物，Myrbetriq获FDA批准</title><link>https://mp.weixin.qq.com/s/cdEZMihEwXY2fNuZAal6tg</link><description></description><content:encoded><![CDATA[关注杜丨又一膀胱功能障碍药物，Myrbetriq获FDA批准]]></content:encoded><pubDate>Fri, 26 Mar 2021 23:39:31 +0800</pubDate></item><item><title>FDA专家组反对NGF抗体</title><link>https://mp.weixin.qq.com/s/7tVVApdTe1qnVm1WNmPFyw</link><description></description><content:encoded><![CDATA[FDA专家组反对NGF抗体]]></content:encoded><pubDate>Fri, 26 Mar 2021 23:39:31 +0800</pubDate></item><item><title>勃林格殷格翰2020年经营业绩取得积极增长</title><link>https://mp.weixin.qq.com/s/_hiLSktXUWjexS1H77ijjQ</link><description></description><content:encoded><![CDATA[勃林格殷格翰2020年经营业绩取得积极增长]]></content:encoded><pubDate>Thu, 25 Mar 2021 21:54:28 +0800</pubDate></item><item><title>晶泰科技携手青煜医药， 联合启动多项AI抗肿瘤管线研发</title><link>https://mp.weixin.qq.com/s/BBL2p7GSCbuSyLb16NH0eA</link><description></description><content:encoded><![CDATA[晶泰科技携手青煜医药， 联合启动多项AI抗肿瘤管线研发]]></content:encoded><pubDate>Thu, 25 Mar 2021 21:54:28 +0800</pubDate></item><item><title>程增江博士受聘成为无锡市会展业发展顾问</title><link>https://mp.weixin.qq.com/s/p1iNz74OMC-r_DzNmIubEQ</link><description></description><content:encoded><![CDATA[程增江博士受聘成为无锡市会展业发展顾问]]></content:encoded><pubDate>Thu, 25 Mar 2021 21:54:28 +0800</pubDate></item><item><title>进入收获期，license-in模式争议漩涡</title><link>https://mp.weixin.qq.com/s/TonZZxaYUZf10v4QENGCYg</link><description></description><content:encoded><![CDATA[进入收获期，license-in模式争议漩涡]]></content:encoded><pubDate>Thu, 25 Mar 2021 21:54:28 +0800</pubDate></item><item><title>预防重症COVID-19效力达100%，阿斯利康宣布其新冠疫苗3期临床试验证实了安全性和有效性</title><link>https://mp.weixin.qq.com/s/QQBi6iMnOfwrJZz7VGik7Q</link><description></description><content:encoded><![CDATA[预防重症COVID-19效力达100%，阿斯利康宣布其新冠疫苗3期临床试验证实了安全性和有效性]]></content:encoded><pubDate>Thu, 25 Mar 2021 21:54:28 +0800</pubDate></item><item><title>同写意第117期丨2021独墅湖国际药品质量研究论坛</title><link>https://mp.weixin.qq.com/s/cOdMFwveqWBFTC8-hOW2Jw</link><description></description><content:encoded><![CDATA[同写意第117期丨2021独墅湖国际药品质量研究论坛]]></content:encoded><pubDate>Wed, 24 Mar 2021 20:01:28 +0800</pubDate></item><item><title>基石药业宣布中国首个选择性RET抑制剂普吉华®（普拉替尼胶囊）获批为肺癌患者提供治疗新选择</title><link>https://mp.weixin.qq.com/s/6wX7HZpGyQwZHg0kSCkBiw</link><description></description><content:encoded><![CDATA[基石药业宣布中国首个选择性RET抑制剂普吉华®（普拉替尼胶囊）获批为肺癌患者提供治疗新选择]]></content:encoded><pubDate>Wed, 24 Mar 2021 20:01:28 +0800</pubDate></item><item><title>一图读懂药明生物2020年业绩成绩单</title><link>https://mp.weixin.qq.com/s/pYwkHVkUlOHrhKBRYsWfAQ</link><description></description><content:encoded><![CDATA[一图读懂药明生物2020年业绩成绩单]]></content:encoded><pubDate>Wed, 24 Mar 2021 20:01:28 +0800</pubDate></item></channel></rss>